US 11319375
Methods and compositions for treating subjects having rheumatoid arthritis
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 11319375 (Methods and compositions for treating subjects having rheumatoid arthritis) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K39/395, A61K39/3955